- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01969396
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
December 22, 2014 updated by: Cook Group Incorporated
To assess the adequacy of an endometrial biopsy sample obtained using sonohysterography.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
2
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Panama City, Panama, 8C6Q1 JGW8N
- Hospital Punta Pacifica
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patient with thickened endometrium
- Abnormal uterine bleeding
Exclusion Criteria:
- Pregnant
- Active pelvic infection
- Pelvic inflammatory disease
- Blood clotting disorders
- Sexually transmitted disease
- Uterine perforation
- Recent cesarean section
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: SonoBiopsy Catheter
|
Catheter utilized in dual role: sonohysterography and endometrial biopsy
Other Names:
|
|
ACTIVE_COMPARATOR: Endometrial biopsy catheter
|
Endometrial sample obtained without the assistance of sonohysterography
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
percentage of adequate endometrial biopsies utilizing sonohysterography
Time Frame: 7 days
|
7 days
|
|
percentage of adequate endometrial biopsies collected without sonohysterography
Time Frame: 7 days
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ricardo Mastellari, MD, Hospital Punta Pacifica
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (ACTUAL)
September 1, 2014
Study Completion (ACTUAL)
September 1, 2014
Study Registration Dates
First Submitted
October 17, 2013
First Submitted That Met QC Criteria
October 21, 2013
First Posted (ESTIMATE)
October 25, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
December 23, 2014
Last Update Submitted That Met QC Criteria
December 22, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Urogenital Neoplasms
- Neoplasms by Site
- Genital Neoplasms, Female
- Uterine Diseases
- Endocrine System Diseases
- Ovarian Cysts
- Cysts
- Ovarian Diseases
- Adnexal Diseases
- Gonadal Disorders
- Hemorrhage
- Menstruation Disturbances
- Uterine Hemorrhage
- Neoplasms
- Polycystic Ovary Syndrome
- Endometrial Neoplasms
- Uterine Neoplasms
- Menorrhagia
Other Study ID Numbers
- 12-012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterine Neoplasms
-
University of AarhusRecruitingUterine Cervical Neoplasm | Mass Screening | Uterine Cervical Disease | Uterine NeoplasmDenmark
-
GlaxoSmithKlineCompletedCervical Cancer | Neoplasms, Uterine Cervix
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingUterine Cervical CancerChina
-
Becton, Dickinson and CompanyTerminatedUterine Cervical NeoplasmUnited States, Canada
-
GlaxoSmithKlineCompletedMetastatic Cervical Cancer | Neoplasms, Uterine CervixUnited States, Germany, Spain, Thailand, Belgium, Italy, Argentina, Canada, Ireland, India, France, Estonia, Mexico
-
Hillel Yaffe Medical CenterUnknownUterine Neoplasms | Uterine Cervical NeoplasmIsrael
-
Abramson Cancer Center of the University of PennsylvaniaCompletedUterine Cervix CancerUnited States
-
Siriwan Tangjitgamol, MDPrince of Songkla University; National Research Council of Thailand; Chiang Mai... and other collaboratorsUnknownUterine Cervical CancerThailand
-
Tampere UniversityGlaxoSmithKline; FinnMedi OyEnrolling by invitation
-
Institut Paoli-CalmettesCompletedUTERINE CERVICAL NEOPLASMS | ENDOMETRIAL NEOPLASMSFrance
Clinical Trials on SonoBiopsy Catheter
-
Washington University School of MedicineNational Cancer Institute (NCI)RecruitingGlioblastoma | Glioblastoma MultiformeUnited States
-
ReFlow Medical, Inc.Not yet recruitingCoronary OcclusionUnited States
-
TeleflexRecruitingVascular Access DeviceUnited States
-
University of British ColumbiaCompletedIschemia | Chronic Pain | Phantom Limb Pain | Vascular DiseaseCanada
-
University College Hospital GalwayCompleted
-
University Hospital, Basel, SwitzerlandBoston Scientific CorporationCompleted
-
Coloplast A/SCompletedIntermittent Urethral CatheterizationDenmark
-
Coloplast A/SCompletedSpinal Cord InjuryDenmark
-
University of Massachusetts, WorcesterCompletedUrinary Retention | Bladder Dysfunction
-
Anhui Provincial HospitalCompletedBiliary CalculiChina